Clinical Trials | July 18, 2023
PredOmix, Core Diagnostics partner to launch OncoVeryx-F
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
OncoVeryx-F, a proprietary test developed by PredOmix, is set to transform early-stage cancer detection
SMPA's diverse portfolio includes six marketed products and a robust pipeline of early- to late-stage assets
PrecisionLife to analyse OXEGENE data to improve mechanistic understanding of endometriosis and identify novel drug targets to support the development of new personalised treatments
OVAPEX is a unique formula developed by the team of scientists and doctors at Green Milk Concepts
GenWorks has scaled up its e-commerce platform in terms of building traffic
Acquisition accelerates Cosette’s women’s health portfolio; with a differentiated, commercial stage, patent protected product
Tadalafil Tablets USP, 20 mg had annual sales of USD 61 mn in the United States (IQVIA MAT April 2023)
Single dose of Ferric Carboxymaltose (FCM) up to 750 mg of iron can be infused in 15 minutes
VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause
The additional $50 million will go towards venture capital firms that specialize in near- and long-term healthcare solutions for patients in low- and middle-income countries
Subscribe To Our Newsletter & Stay Updated
